SPIVCs are the most commonly used device to access a patient's blood vessels. Blood exposure, including exposure that may occur upon insertion of an SPIVC, presents a risk to clinicians and patients. According to multiple published studies, up to 37.8 percent of healthcare workers report having experienced at least one blood or body fluid exposure in the preceding year (1, 2, 3). A recent report from the International Healthcare Worker Safety Center at the University of Virginia shows that nurses are at greatest risk, reporting 48.6 percent of blood or bodily fluid exposures(4).
About BDBD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.
(1) Doebbeling BN, Vaughn TE, McCoy KD, Beekmann SE, Woolson RF, Ferguson KJ, et al. Percutaneous injury, blood exposure, and adherence to standard precautions: are hospital-based health care providers still at risk? Clin Infect Dis. 2003 Oct 15;37(8):1006-13.
(2) Zhang M, Wang H,
|SOURCE BD (Becton, Dickinson and Company)|
Copyright©2010 PR Newswire.
All rights reserved